Join this webinar to gain insights to drive faster and more efficient development in oncology.
TORONTO (PRWEB)
September 21, 2020
In today’s competitive oncology landscape, researchers are under pressure to ensure their clinical trial designs are both innovative and efficient. It’s increasingly common for trials to incorporate multiple therapies and diseases. At the same time, oncology researchers often try to answer numerous complex hypotheses in one study.
Join this webinar to gain insights to drive faster and more efficient development in oncology. You’ll hear about complex innovative trial design approaches in oncology clinical development and maximizing the speed of molecule development. The next segment will explore the application and value of biomarkers in adaptive oncology trial designs today and perspectives on the future.
Join Dr. Sarah Blagden, Associate Professor of Medical Oncology, University of Oxford and Maria J. Prendes, PhD, MS, Head of Oncology, Biomarker Solution Center, Covance in a live webinar on Thursday, October 1, 2020 at 10am EDT (3pm BST/UK).
For more information or to register for this event, visit Accelerating Drug Development Timelines – Evolution in Trial Design Approaches in Oncology.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Share article on social media or email: